» Articles » PMID: 28236431

Catamenial-like Seizure Exacerbation in Mice with Targeted Ablation of Extrasynaptic δGABA-a Receptors in the Brain

Overview
Journal J Neurosci Res
Specialty Neurology
Date 2017 Feb 26
PMID 28236431
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Neurosteroids play a key role in catamenial epilepsy, a menstrual cycle-related seizure clustering in women with epilepsy. While neurosteroids act on all GABA-A receptor isoforms, they cause greater effects on extrasynaptic δGABA-A receptors that mediate tonic inhibition in the brain. Previously, we identified a potential GABA-A receptor mechanism for catamenial epilepsy. However, the precise functional role of extrasynaptic δGABA-A receptors in the pathophysiology of catamenial epilepsy remains unclear. In this study, we utilized mice lacking extrasynaptic δGABA-A receptors (δKO) to investigate whether reduction of tonic inhibition affects catamenial seizure susceptibility or intensity. Intact female wildtype (WT) and δKO mice were subjected to hippocampus kindling until they exhibited stage 5 seizures. Elevated gonadal hormone-based neurosteroid levels were induced by standard gonadotropin regimen and neurosteroid withdrawal (NSW) was triggered by finasteride. NSW increased susceptibility to, as well the intensity of evoked catamenial-like seizures in WT and δKO mice. However, fully kindled δKO mice exhibited an accelerated and augmented response to NSW, with a more rapid increase in seizure susceptibility and intensity than WT mice undergoing the NSW paradigm. Moreover, δKO mice in NSW showed reduced benzodiazepine sensitivity, but in stark contrast to the increased neurosteroid sensitivity observed in WT animals, δKO mice displayed no change in neurosteroid sensitivity in response to NSW. The increased catamenial seizure exacerbation and alterations in antiseizure drug responses are consistent with NSW-induced changes in the abundance of δGABA-A receptors. Collectively, these findings provide evidence of a potential protective role for extrasynaptic δGABA-A receptors in catamenial-like seizures. © 2017 Wiley Periodicals, Inc.

Citing Articles

Neurosteroids as Novel Anticonvulsants for Refractory Status Epilepticus and Medical Countermeasures for Nerve Agents: A 15-Year Journey to Bring Ganaxolone from Bench to Clinic.

Reddy D J Pharmacol Exp Ther. 2023; 388(2):273-300.

PMID: 37977814 PMC: 10801762. DOI: 10.1124/jpet.123.001816.


Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy.

Reddy D, Mbilinyi R, Estes E Psychopharmacology (Berl). 2023; 240(9):1841-1863.

PMID: 37566239 PMC: 10471722. DOI: 10.1007/s00213-023-06427-2.


Neurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocrine disorders in women.

Reddy D J Neuroendocrinol. 2021; 34(2):e13028.

PMID: 34506047 PMC: 9247111. DOI: 10.1111/jne.13028.


Extrasynaptic γ-aminobutyric acid type A receptor-mediated sex differences in the antiseizure activity of neurosteroids in status epilepticus and complex partial seizures.

Reddy D, Carver C, Clossen B, Wu X Epilepsia. 2019; 60(4):730-743.

PMID: 30895610 PMC: 6447432. DOI: 10.1111/epi.14693.


Zinc reduces antiseizure activity of neurosteroids by selective blockade of extrasynaptic GABA-A receptor-mediated tonic inhibition in the hippocampus.

Chuang S, Reddy D Neuropharmacology. 2018; 148:244-256.

PMID: 30471294 PMC: 6424640. DOI: 10.1016/j.neuropharm.2018.11.031.


References
1.
Gulinello M, Gong Q, Li X, Smith S . Short-term exposure to a neuroactive steroid increases alpha4 GABA(A) receptor subunit levels in association with increased anxiety in the female rat. Brain Res. 2001; 910(1-2):55-66. PMC: 4170586. DOI: 10.1016/s0006-8993(01)02565-3. View

2.
Carver C, Wu X, Gangisetty O, Reddy D . Perimenstrual-like hormonal regulation of extrasynaptic δ-containing GABAA receptors mediating tonic inhibition and neurosteroid sensitivity. J Neurosci. 2014; 34(43):14181-97. PMC: 4205546. DOI: 10.1523/JNEUROSCI.0596-14.2014. View

3.
Bazan A, Montenegro M, Cendes F, Min L, Guerreiro C . Menstrual cycle worsening of epileptic seizures in women with symptomatic focal epilepsy. Arq Neuropsiquiatr. 2005; 63(3B):751-6. DOI: 10.1590/s0004-282x2005000500006. View

4.
Scharfman H, Goodman J, Rigoulot M, Berger R, Walling S, Mercurio T . Seizure susceptibility in intact and ovariectomized female rats treated with the convulsant pilocarpine. Exp Neurol. 2005; 196(1):73-86. PMC: 2494578. DOI: 10.1016/j.expneurol.2005.07.007. View

5.
Pack A, Reddy D, Duncan S, Herzog A . Neuroendocrinological aspects of epilepsy: important issues and trends in future research. Epilepsy Behav. 2011; 22(1):94-102. DOI: 10.1016/j.yebeh.2011.02.009. View